Clinical Trials Directory

Trials / Unknown

UnknownNCT01458873

Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Spontaneously Breathing Adult Volunteers

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Sheba Medical Center · Other Government
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Vascular access in patients carries a significant risk of accidental extravasation of intravenous (IV) fluids and medications with the potential for tissue injury. This prospective controlled study assessed the diagnostic utility of using intravenous diluted sodium bicarbonate to confirm placement of IV catheters in volunteers . Diluted sodium bicarbonate or 0.9% normal saline, will be injected in a randomized order while end-tidal carbon dioxide in the exhaled air will be monitored. The investigators hypothesize that the injected bicarbonate will dissolve into carbon dioxide and water and cause a transient increase in the measured exhaled CO2. The effect is unique to bicarbonate and will not appear once normal saline is injected. the safety of the administration of bicarbonate on the metabolic profile of the volunteers will be assessed by measurement of venous blood pH and electrolytes.

Detailed description

Vascular access in patients carries a significant risk of accidental extravasation of intravenous (IV) fluids and medications with the potential for tissue injury. This prospective controlled study assessed the diagnostic utility of using intravenous diluted sodium bicarbonate to confirm placement of IV catheters in volunteers . Diluted sodium bicarbonate or 0.9% normal saline, will be injected in a randomized order while end-tidal carbon dioxide in the exhaled air will be monitored. The investigators hypothesize that the injected bicarbonate will dissolve into carbon dioxide and water and cause a transient increase in the measured exhaled CO2. Arbitrary increase of more than 10%in end-tidal carbon dioxide is considered as a positive response. The effect is unique to bicarbonate and will not appear once normal saline is injected. the safety of the administration of bicarbonate on the metabolic profile of the volunteers will be assessed by measurement of venous blood pH and electrolytes.

Conditions

Interventions

TypeNameDescription
DRUGsodium bicarbonate 4.2%diluted sodium bicarbonate 50 ml
DRUGdiluted sodium bicarbonate 2.1%50ml
DRUGnormal saline50ml

Timeline

Start date
2011-10-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2011-10-25
Last updated
2011-11-01

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01458873. Inclusion in this directory is not an endorsement.